Novartis Urges Court to Hand It Quick Win in Drug Price Battle

Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in a motion for summary judgment against the US government.

Novartis urged the US District Court for the District of New Jersey to declare the Centers for Medicare & Medicaid Services’ price-setting provisions unconstitutional and to enjoin the government from enforcing it against the company.

“It recklessly gambles with public health and violates core tenets of our constitutional order, for no purpose other than to advance the government’s preferred narrative and then shield the government from any resulting political accountability for its decisions. It ...